Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Giovanni Luigi Pastorino | Researchclopedia

Back to researchers

Giovanni Luigi Pastorino

Vita-Salute San Raffaele University

9

Works

17

Citations

1

h-index

1

i10-index

Research Topics

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Renal cell carcinoma treatment

Affiliations

Vita-Salute San Raffaele University2024–2026

Mylan (South Africa)2024–2024

Istituti di Ricovero e Cura a Carattere Scientifico2025–2025

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele2025–2025

Top Works

First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer

Chiara Mercinelli,Marco Moschini,et al.

202415 citations

Urinary and Genital Oncology Studies

Prostate Cancer Diagnosis and Treatment

The role of MRI in muscle-invasive bladder cancer: an update from the last two years

Giovanni Luigi Pastorino,Chiara Mercinelli,et al.

20241 citations

Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study

Andrea Necchi,Brigida A Maiorano,et al.

20261 citations

Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence study

Brigida Anna Maiorano,Antonio Cigliola,et al.

20250 citations

A0659 – Outcomes of immune-checkpoint inhibitor rechallenge in urothelial carcinoma: Results from a global real-world evidence study

Brigida Anna Maiorano,Antonio Cigliola,et al.

20250 citations

Genomic characteristics of patients with metastatic hormone-sensitive prostate cancer treated with ARPI-based therapy: A single-center analysis.

Brigida Anna Maiorano,Antonio Cigliola,et al.

20250 citations

Outcomes of different therapeutic modalities for patients with metachronous oligometastatic renal-cell carcinoma (RCC): Analyses of a single-institution database.

Antonio Cigliola,Chiara Re,et al.

20250 citations

Outcomes of immune-checkpoint inhibitor rechallenge in urothelial carcinoma: Results from a global real-world evidence study.

Brigida Anna Maiorano,Antonio Cigliola,et al.

20250 citations

3093P Circulating immune-biomarkers of response to neoadjuvant Sacituzumab Govitecan (SG) alone and with pembrolizumab (pembro) in muscle-invasive bladder cancer (MIBC): Secondary analyses from SURE-01 and SURE-02 trials

Giovanni Luigi Pastorino,Camilla Marchigiani,et al.

20250 citations